Brainstorm Cell Therapeutics Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
7.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.18
|
-0.19
|
-0.01
|
-5.56%
|
|
2022-06-30
|
-0.15
|
-0.19
|
-0.04
|
-26.67%
|
|
2022-03-31
|
-0.13
|
-0.15
|
-0.02
|
-15.38%
|
|
2021-12-31
|
-0.20
|
-0.17
|
0.03
|
15.00%
|
|
2021-09-30
|
-0.20
|
-0.15
|
0.05
|
25.00%
|
|
2021-06-30
|
-0.20
|
-0.17
|
0.03
|
15.00%
|
|
2021-03-31
|
-0.26
|
-0.19
|
0.07
|
26.92%
|
|
2020-12-31
|
-0.43
|
-0.37
|
0.06
|
13.95%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.53
|
|
2021-12-31
|
-0.68
|
|
2020-12-31
|
-1.08
|
|
2019-12-31
|
-1.06
|
|
2018-12-31
|
-0.70
|
|
2017-12-31
|
-0.27
|
|
2016-12-31
|
-0.28
|
|
2015-12-31
|
-0.45
|
|
2014-12-31
|
-0.68
|
|
2013-12-31
|
-0.51
|
|
2012-12-31
|
-0.38
|
|
2011-12-31
|
-0.49
|
|
2010-12-31
|
-0.41
|
|
2009-12-31
|
-0.46
|
|
2008-12-31
|
-1.08
|
|
2007-12-31
|
-3.47
|
|
2006-12-31
|
-3.43
|
|
2004-12-31
|
-13.84
|
|
2003-12-31
|
-0.03
|